Recurrent herpes simplex infection of eye
|
disease |
Infections; Eye Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Genomic Instability
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell or Molecular Dysfunction
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hajdu-Cheney Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
8
|
13
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Squamous cell carcinoma of nasopharynx
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Bile duct hyperplasia
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
GLOMUVENOUS MALFORMATIONS
|
disease |
Neoplasms
|
Disease or Syndrome
|
13
|
3
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Papillary renal cell carcinoma, sporadic
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
17
|
30
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Carcinoma in situ of endometrium
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
18
|
|
0.300 |
None |
|
0 |
|
|
|
Keratitis, Herpetic
|
disease |
Infections; Eye Diseases
|
Disease or Syndrome
|
23
|
1
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Malignant tumor of peritoneum
|
disease |
Digestive System Diseases; Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
23
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Undifferentiated carcinoma of nasopharynx
|
disease |
|
Neoplastic Process
|
23
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Serous cystadenocarcinoma ovary
|
disease |
Neoplasms
|
Neoplastic Process
|
24
|
99
|
0.100 |
None |
1.000 |
1 |
4
|
2016 |
2016 |
Malignant Uterine Corpus Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
26
|
152
|
0.100 |
None |
1.000 |
1 |
7
|
2016 |
2016 |
Pigmented Basal Cell Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hemorrhagic Disorders
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
30
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Lichen disease
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Uterine Corpus Carcinosarcoma
|
disease |
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hermaphroditism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
34
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Chlamydia trachomatis infection
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
36
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Neonatal chlamydial conjunctivitis
|
disease |
Infections; Eye Diseases
|
Disease or Syndrome
|
38
|
3
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Trachoma
|
disease |
Infections; Eye Diseases
|
Disease or Syndrome
|
39
|
3
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Activated B-cell type diffuse large B-cell lymphoma
|
disease |
|
Neoplastic Process
|
39
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Uterine Carcinosarcoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
41
|
80
|
0.110 |
None |
1.000 |
2 |
7
|
2016 |
2019 |
Platinum-Resistant Ovarian Carcinoma
|
disease |
|
Neoplastic Process
|
41
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Childhood Brain Neoplasm
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
44
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |